Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters - Takeaways - MDSpire

Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters

  • By

  • Jeongin Yoo

  • Ijin Joo

  • Sun Kyung Jeon

  • Junghoan Park

  • Soon Ho Yoon

  • February 23, 2024

  • 0 min

Share

  • 1

    Hepatic steatosis is a key feature of non-alcoholic fatty liver disease, traditionally assessed via invasive liver biopsy.

  • 2

    Non-invasive imaging techniques like MRI-PDFF and quantitative ultrasound are increasingly preferred for evaluating hepatic steatosis.

  • 3

    CT is a cost-effective tool for hepatic steatosis screening, despite its limitations in assessing mild cases and reliance on ionizing radiation.

  • 4

    This study investigates the clinical utility of fully automated 3D organ segmentation for assessing hepatic steatosis using MRS-PDFF as the reference standard.

  • 5

    Two methods were used to assess CT attenuation values: a manual ROI-based method and a 3D automated volumetric method on pre-contrast and post-contrast images.

Original Source(s)

Related Content